These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 19748437)
21. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Bobes RJ; Hernández M; Márquez C; Fragoso G; García E; Parkhouse RM; Harrison LJ; Sciutto E; Fleury A Trop Med Int Health; 2006 Jun; 11(6):943-50. PubMed ID: 16772017 [TBL] [Abstract][Full Text] [Related]
22. Use of IgG avidity to indirectly monitor epizootic transmission of sin nombre virus in deer mice (Peromyscus maniculatus). Safronetz D; Lindsay R; Hjelle B; Medina RA; Mirowsky-Garcia K; Drebot MA Am J Trop Med Hyg; 2006 Dec; 75(6):1135-9. PubMed ID: 17172381 [TBL] [Abstract][Full Text] [Related]
23. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Sickinger E; Gay-Andrieu F; Jonas G; Schultess J; Stieler M; Smith D; Hausmann M; Stricker R; Stricker R; Dhein J; Braun HB Diagn Microbiol Infect Dis; 2008 Nov; 62(3):235-44. PubMed ID: 18715735 [TBL] [Abstract][Full Text] [Related]
24. Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children. Atluri SR; Singhi P; Khandelwal N; Malla N Acta Trop; 2009 Apr; 110(1):22-7. PubMed ID: 19161966 [TBL] [Abstract][Full Text] [Related]
25. Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Winkler AS; Blocher J; Auer H; Gotwald T; Matuja W; Schmutzhard E Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):1032-8. PubMed ID: 18571212 [TBL] [Abstract][Full Text] [Related]
26. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran. Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997 [TBL] [Abstract][Full Text] [Related]
27. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Fleury A; Escobar A; Fragoso G; Sciutto E; Larralde C Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):243-50. PubMed ID: 20116079 [TBL] [Abstract][Full Text] [Related]
28. A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis. Chavarria A; Fleury A; Bobes RJ; Morales J; Fragoso G; Sciutto E Microbes Infect; 2006 Apr; 8(4):1082-9. PubMed ID: 16520076 [TBL] [Abstract][Full Text] [Related]
29. Detection of specific cysticercus antigen in the urine for diagnosis of neurocysticercosis. Parija M; Biswas R; Harish BN; Parija SC Acta Trop; 2004; 92(3):253-60. PubMed ID: 15533295 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of commercial rubella immunoglobulin G avidity assays. Mubareka S; Richards H; Gray M; Tipples GA J Clin Microbiol; 2007 Jan; 45(1):231-3. PubMed ID: 17093027 [TBL] [Abstract][Full Text] [Related]
31. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Lachaud L; Calas O; Picot MC; Albaba S; Bourgeois N; Pratlong F Diagn Microbiol Infect Dis; 2009 Jul; 64(3):267-74. PubMed ID: 19395217 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of excretory secretory and 10-30 kDa antigens of Taenia solium Cysticerci by EITB assay for the diagnosis of neurocysticercosis. Atluri SR; Singhi P; Khandelwal N; Malla N Parasite Immunol; 2009 Mar; 31(3):151-5. PubMed ID: 19222787 [TBL] [Abstract][Full Text] [Related]
33. Cysticercosis/taeniasis: recent advances in serological and molecular diagnoses. Yamasaki H; Sato MO; Sako Y; Nakao M; Nakaya K; Mamuti W; Craig PS; Margono SS; Ito A Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 2():98-102. PubMed ID: 19230578 [TBL] [Abstract][Full Text] [Related]
34. HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently. Kashi VP; Jacob RA; Paul S; Nayak K; Satish B; Swaminathan S; Satish KS; Ranga U Vaccine; 2009 Nov; 27(48):6739-47. PubMed ID: 19744585 [TBL] [Abstract][Full Text] [Related]
35. IgG intrathecal synthesis and specific antibody index in patients with neurocysticercosis. Machado LR; Livramento JA; Vaz AJ; Bueno EC; Mielli SR; Bastouly V; Nobrega JP Arq Neuropsiquiatr; 2002 Jun; 60(2-B):395-9. PubMed ID: 12131939 [TBL] [Abstract][Full Text] [Related]
36. Lymphocyte transformation test: a new method for diagnosis of neurocysticercosis. Prasad A; Prasad KN; Yadav A; Gupta RK; Pradhan S; Jha S; Tripathi M; Husain M Diagn Microbiol Infect Dis; 2008 Jun; 61(2):198-202. PubMed ID: 18272315 [TBL] [Abstract][Full Text] [Related]